{"id":"https://openalex.org/W2054477293","doi":"https://doi.org/10.1097/00005053-197210000-00003","title":"CHANGES IN STAFF ANXIETY AND ATTITUDES DURING A DOUBLE BLIND STUDY OF HALOPERIDOL IN ACUTE SCHIZOPHRENICS WITHIN A STRUCTURED MILIEU","display_name":"CHANGES IN STAFF ANXIETY AND ATTITUDES DURING A DOUBLE BLIND STUDY OF HALOPERIDOL IN ACUTE SCHIZOPHRENICS WITHIN A STRUCTURED MILIEU","alternate_titles":[],"publication_year":1972,"publication_date":"1972-10-01","ids":{"openalex":"https://openalex.org/W2054477293","doi":"https://doi.org/10.1097/00005053-197210000-00003","mag":"2054477293","pmid":"https://pubmed.ncbi.nlm.nih.gov/4561348"},"language":"en","primary_location":{"id":"doi:10.1097/00005053-197210000-00003","doi":"https://doi.org/10.1097/00005053-197210000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005053-197210000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S13566964","display_name":"The Journal of Nervous and Mental Disease","issn_l":"0022-3018","issn":["0022-3018","1539-736X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Nervous and Mental Disease","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2054477293"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076181450","display_name":"MAN MOHAN SINGH","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"MAN MOHAN SINGH","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Bronx State Hospital, 1500 Waters Place, Bronx, New York 10461"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Bronx State Hospital, 1500 Waters Place, Bronx, New York 10461","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110091518","display_name":"William J. DiScipio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"WILLIAM J. DISCIPIO","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Bronx State Hospital, 1500 Waters Place, Bronx, New York 10461"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Bronx State Hospital, 1500 Waters Place, Bronx, New York 10461","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5076181450"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3407,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.86286522,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"155","issue":"4","first_page":"245","last_page":"256"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8848000168800354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8848000168800354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13944","display_name":"Psychiatric care and mental health services","score":0.0471000000834465,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12869","display_name":"Occupational Health and Burnout","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/employee-anxiety","display_name":"employee anxiety","score":0.8949999809265137},{"id":"https://openalex.org/keywords/employee-attitudes","display_name":"employee attitudes","score":0.8700000047683716},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.968999981880188},{"id":"https://openalex.org/keywords/acute-schizophrenia","display_name":"acute schizophrenia","score":0.8519999980926514},{"id":"https://openalex.org/keywords/neuroticism","display_name":"neuroticism","score":0.8669999837875366},{"id":"https://openalex.org/keywords/eysenck-personality-inventory","display_name":"Eysenck Personality Inventory","score":0.8759999871253967},{"id":"https://openalex.org/keywords/benztropine","display_name":"benztropine","score":0.8289999961853027},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8309999704360962},{"id":"https://openalex.org/keywords/psychiatric-ward-staff","display_name":"psychiatric ward staff","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C94612546","wikidata":"https://www.wikidata.org/wiki/Q1540168","display_name":"Neuroticism","level":3,"score":0.7935149669647217},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.7741903066635132},{"id":"https://openalex.org/C2910393698","wikidata":"https://www.wikidata.org/wiki/Q415026","display_name":"Benztropine","level":3,"score":0.7679149508476257},{"id":"https://openalex.org/C2781214261","wikidata":"https://www.wikidata.org/wiki/Q2729863","display_name":"Hostility","level":2,"score":0.7168833613395691},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6098843216896057},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.5721067786216736},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5492590665817261},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.5131881833076477},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3269602656364441},{"id":"https://openalex.org/C187288502","wikidata":"https://www.wikidata.org/wiki/Q641118","display_name":"Personality","level":2,"score":0.2441730499267578},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0764491856098175},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001291","descriptor_name":"Attitude of Health Personnel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001590","descriptor_name":"Benztropine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005069","descriptor_name":"Evaluation Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008884","descriptor_name":"Milieu Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009069","descriptor_name":"Movement Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009497","descriptor_name":"Neurotic Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010555","descriptor_name":"Personality Inventory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005053-197210000-00003","doi":"https://doi.org/10.1097/00005053-197210000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005053-197210000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S13566964","display_name":"The Journal of Nervous and Mental Disease","issn_l":"0022-3018","issn":["0022-3018","1539-736X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Nervous and Mental Disease","raw_type":"journal-article"},{"id":"pmid:4561348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4561348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of nervous and mental disease","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1972023082","https://openalex.org/W1994839422","https://openalex.org/W2473505328","https://openalex.org/W1977725618","https://openalex.org/W2362759458","https://openalex.org/W2440006225","https://openalex.org/W2076204153","https://openalex.org/W2032462883","https://openalex.org/W2105826763","https://openalex.org/W2332615787"],"abstract_inverted_index":{"The":[0,160],"changes":[1,11,62,82,99,184,291],"in":[2,12,50,60,63,83,130,185,219,231,261,279,292],"staff":[3,36,43,57,64,84,104,168,255,271,280],"anxiety":[4,44,65,85,117,169,232,251,281],"and":[5,7,45,55,58,66,86,124,170,222,227,233,252,282,294],"attitudes":[6,67,235,284],"their":[8],"relationship":[9],"to":[10,41,118,136,267],"drug-treated":[13],"schizophrenics":[14],"were":[15,80,100,125,202],"longitudinally":[16],"investigated":[17],"during":[18,176],"a":[19,26,127,156,164,177,205,228],"double":[20],"blind":[21],"study":[22],"of":[23,92,97,139,167,190,199,211,270],"haloperidol":[24,191],"within":[25,120],"structured,":[27,157],"reality-oriented":[28,158],"ward":[29,35,132,178],"setting.":[30],"A":[31],"specially":[32],"designed":[33],"self-administered":[34],"questionnaire":[37],"was":[38,71,163,173,216,264,285],"used":[39],"periodically":[40],"monitor":[42],"attitudes.":[46,171],"It":[47,70,144],"proved":[48],"sensitive":[49],"discriminating":[51],"between":[52],"the":[53,74,90,93,103,111,121,140,188,193,212,239,244,249,268,277,299],"\u201canxiety-prone\u201d":[54],"\u201cstable\u201d":[56],"also":[59],"measuring":[61],"over":[68],"time.":[69],"validated":[72],"against":[73],"Eysenck":[75],"Personality":[76],"Inventory":[77],"(EPI).":[78],"There":[79],"significant":[81],"attitude":[87],"scores":[88,109],"along":[89],"course":[91,189],"study.":[94],"Almost":[95],"all":[96],"these":[98],"contributed":[101],"by":[102,204,288,298],"who":[105],"received":[106,195],"high":[107,150],"\u201cneuroticism\u201d":[108],"on":[110],"EPI.":[112],"They":[113],"reacted":[114],"with":[115,149,181],"much":[116],"pressures":[119],"therapeutic":[122,142],"situation":[123],"probably":[126,296],"major":[128,165],"factor":[129],"generating":[131],"crises":[133],"which":[134,201],"led":[135],"serious":[137],"disruption":[138],"structured":[141],"program.":[143],"seemed,":[145],"therefore,":[146],"that":[147,259,276],"persons":[148],"neuroticism":[151],"might":[152],"be":[153],"unsuitable":[154],"for":[155],"milieu.":[159],"patient":[161,245,262],"behavior":[162,246],"determinant":[166],"This":[172],"best":[174],"seen":[175],"crisis":[179],"associated":[180],"benztropine-induced":[182,289],"nontherapeutic":[183,290],"patients.":[186],"Along":[187],"treatment,":[192],"patients":[194,226,293],"two":[196],"3-week":[197,206],"courses":[198],"benztropine":[200,213],"separated":[203],"benztropine-free":[207,241],"period.":[208],"In":[209,238],"both":[210],"periods,":[214],"there":[215],"an":[217],"increase":[218,278],"hostility,":[220],"suspiciousness,":[221],"paranoid":[223],"belligerence":[224],"among":[225,236,254],"sharp":[229],"rise":[230],"negative":[234,283],"staff.":[237],"intervening":[240],"weeks,":[242],"however,":[243],"improved":[247],"while":[248],"increased":[250],"conflict":[253],"persisted,":[256],"thus":[257],"indicating":[258],"reduction":[260],"disturbance":[263],"not":[265],"related":[266],"resolution":[269],"tension.":[272],"Rather":[273],"it":[274],"seemed":[275],"primarily":[286],"triggered":[287],"then":[295],"maintained":[297],"ensuing":[300],"conflicts.":[301]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2054477293","counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
